FMO5 and brain ischemia: We have demonstrated that pharmacological inhibition of NADPH oxidases using the specific NADPH oxidase inhibitor VAS2870 [15],[32]–[34] protects mice from brain ischemia within a clinically meaningful 2-h time window.